GUARDANT HEALTH, INC

GH
Delayed Quote. Delayed  - 02/26 04:00:00 pm
147.18USD -1.52%
Upcoming events on GUARDANT HEALTH, INC.
02/26/21 | 04:20pm SVB Leerink Global Healthcare Conference
03/02/21 | 11:10am Cowen & Co. Health Care Conference
05/13/21 Q1 2021 Earnings Release (Projected)
08/11/21 Interim 2021 Earnings Release (Projected)

Past events on GUARDANT HEALTH, INC.
02/24/21 | 05:00pmFY 2020 Earnings Call
02/24/21FY 2020 Earnings Release
01/15/21American society of clinical oncology virtual gastrointestinal cancers symposium - abstract no : #61
01/15/21American society of clinical oncology virtual gastrointestinal cancers symposium - abstract no : #11

Upcoming sector events for GUARDANT HEALTH, INC.
02/26/21 | 04:35pm REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 010
02/26/21 REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 290
02/26/21 REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 447
02/26/21 REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 425

Past sector events for GUARDANT HEALTH, INC.
02/25/21 | 01:40pmGILEAD SCIENCES, INC. : SVB Leerink Global Healthcare Conference
02/25/21 | 01:40pmEXACT SCIENCES CORPORATION : SVB Leerink Global Healthcare Conference
02/25/21IOVANCE BIOTHERAPEUTICS, INC. : FY 2020 Earnings Release
02/25/21VIR BIOTECHNOLOGY, INC. : FY 2020 Earnings Release

Annual results
Previous yearNext Year
Annual results20192020 (e)
Sales
M $
Released
Forecast
Spread
214
206
3,9%

285
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-71,0
-76,5
7,3%

-203
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-82,4
-86,3
4,6%

-218
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-69,7
-73,7
5,4%

-211
Net income
M $
Released
Forecast
Spread
-75,7
-78,6
3,8%

-218
EPS
$
Released
Forecast
Spread
-0,84
-0,88
5,0%

-2,19
Announcement Date02/24/2020


Quarterly / Semiannualy publications
Previous periodNext period
Quarterly results2020 Q32020 Q4 (e)
Sales
M $
Released
Forecast
Spread
74,6
66,0
13%

76,7
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-69,9
-32,1
-118%

-55,4
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-74,3
-41,3
-80%

-63,9
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-71,6
-39,4
-82%

-62,9
Net income
M $
Released
Forecast
Spread
-77,7
-40,3
-93%

-62,5
EPS
$
Released
Forecast
Spread
-0,78
-0,40
-96%

-0,59
Announcement Date11/05/2020

Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise